NGM Biopharmaceuticals Inc
NGMDelisted Apr 5, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426332
NGM Biopharmaceuticals Inc was delisted on Apr 5, 2024; its insiders filed their last Form 4 on Apr 8, 2024; 75 institutions reported holding it in 13F filings for Q1 2024, worth $55.1M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding NGM Biopharmaceuticals Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 107 | 121 | +14 |
| Shares | 43.1M | 45.2M | +2.15M (+5.0%) |
| Value | $849.7M | $951.2M | +$101.5M (+12.0%) |
New holders (26)
Institutions that held NGM Biopharmaceuticals Inc at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (12)
Institutions that held NGM Biopharmaceuticals Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $31.0M |
| Aquilo Capital Management, LLC | 1,194,237 | $23.6M |
| EcoR1 Capital, LLC | 143,567 | $2.83M |
| HRT Financial LP | 97,313 | $1.92M |
| Verition Fund Management LLC | 45,739 | $902.0K |
| Ergoteles LLC | 31,200 | $615.0K |
| Schonfeld Strategic Advisors LLC | 30,253 | $597.0K |
| First Trust Advisors LP | 19,551 | $386.0K |
| Stifel Financial Corp | 17,550 | $346.0K |
| Susquehanna International Group, LLP | 14,047 | $277.0K |
| Acadian Asset Management LLC | 4,305 | $85.0K |
| Simplex Trading, LLC | 4 | $0 |